Zhejiang Jianfeng Group Co., Ltd.

600668

CNE000000B18

Construction Materials

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 16/07/2024 BST			5-day change	1st Jan Change
7.66 ^CNY	+0.13%		+0.52%	-30.68%

06-05	Zhejiang Jianfeng Group Receives Drug Registration for Sodium Hyaluronate Eye Drops	MT
05-28	China Approves Jianfeng's Marketing Application for Antibiotic Raw Material	MT

Zhejiang Jianfeng Group Co., Ltd. signed a transfer agreement to acquire Guizhou Huangping Gulong Mingchuan Cement Co., Ltd. from Qi Chunhua, Gao Zhimin and Sichuan Mingchuan Chengyu Electromechanical Equipment Co., Ltd. for CNY 31.7 million.

January 02, 2019

Zhejiang Jianfeng Group Co., Ltd. (SHSE:600668) signed a transfer agreement to acquire Guizhou Huangping Gulong Mingchuan Cement Co., Ltd. from Qi Chunhua, Gao Zhimin and Sichuan Mingchuan Chengyu Electromechanical Equipment Co., Ltd. for CNY 31.7 million on December 29, 2018. As per the terms, transfer price will be paid within 7 days since signing of the agreement. The transaction has been approved by the 9th meeting of the 10th directorate of Zhejiang Jianfeng Group Co., Ltd. on December 29, 2018.

Latest news about Zhejiang Jianfeng Group Co., Ltd.

Zhejiang Jianfeng Group Receives Drug Registration for Sodium Hyaluronate Eye Drops	06-05	MT
China Approves Jianfeng's Marketing Application for Antibiotic Raw Material	05-28	MT
Zhejiang Jianfeng's Pharmaceutical Unit Gets Nod to Market Anti-Tumor Drug	05-14	MT
Jianfeng Group's Pharma Unit Gets Nod to Sell Glaucoma Eye Drops	05-07	MT
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-29	CI
Zhejiang Jianfeng Unit's Gastroesophageal Reflux Drug Chosen for China's Centralized Procurement	11-08	MT
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23	CI
Jianfeng Group's Pharmaceutical Unit Gets US FDA's Nod to Trial Lung Cancer Drug	26/10/23	MT
Zhejiang Jianfeng's Unit Gets Nod to Make Changes to Mycophenolate Mofetil Capsules	19/09/23	MT
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23	CI
Zhejiang Jianfeng Registers Valsartan Amlodipine Tablet in China	25/05/23	MT
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23	CI
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	17/04/23	CI
Production Line of Zhejiang Jianfeng's Pharma Unit Passes Regulatory Inspection	08/02/23	MT
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	30/10/22	CI
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	26/08/22	CI
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22	CI
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	18/04/22	CI
Three Chinese Drugmakers Deny Receiving Orders From Pfizer	15/02/22	MT
Zhejiang Jianfeng Group Co., Ltd.(XSSC:600668) dropped from S&P Global BMI Index	20/12/21	CI
Xinjiang Tianshan Cement Raises $14.7 Billion From Private Share Sale	01/11/21	MT
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	29/10/21	CI
Xinjiang Tianshan Cement Co., Ltd. completed the acquisition of stakes in South West Cement Company Limited and South Cement Company Limited from a group of sellers.	27/09/21	CI
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	30/08/21	CI

Chart Zhejiang Jianfeng Group Co., Ltd.

Duration

Period

More charts

Company Profile

ZHE JIANG JIAN FENG GROUP CO., LTD is a China-based company, principally engaged in the manufacture and distribution of cement and pharmaceuticals. The Company mainly conducts its cement business in Hubei Province, Yunnan Province, Zhejiang Province and Guangxi Province. The Company provides pharmaceuticals, including anti-infective drugs, antipyretic and analgesic drugs, drugs for cardiovascular system diseases, drugs for diabetes mellitus, bulk drugs, intermediates and over the counter (OTC) products. The Company is also engaged in the provision of health products, and the manufacture and distribution of cables. The Company conducts its business in domestic markets.

Sector

Construction Materials

Calendar

27/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Cement & Concrete Manufacturing

	1st Jan change	Capi.
ZHEJIANG JIANFENG GROUP CO., LTD.	-30.68%	362M
HOLCIM LTD	+26.57%	52.73B
ANHUI CONCH CEMENT COMPANY LIMITED	+13.08%	16.91B
JAMES HARDIE INDUSTRIES PLC	-5.08%	14.63B
SHREE CEMENT LIMITED	-2.61%	12.05B
EAGLE MATERIALS INC.	+16.16%	8.32B
TCC GROUP HOLDINGS CO., LTD.	-1.00%	7.88B
BUZZI S.P.A.	+34.86%	7.56B
DANGOTE CEMENT PLC	+105.28%	6.71B
TIANSHAN MATERIAL CO., LTD.	-19.16%	5.32B